Impact and use of prasugrel versus Clopidogrel as a function of age among patients with acute coronary syndrome undergoing percutaneous coronary intervention

被引：0
|
作者：
Chandrasekhar, J. [1 ]
Baber, U. [1 ]
Sartori, S. [1 ]
Aquino, M. [1 ]
Henry, T. [2 ]
Rao, S. [3 ]
Snyder, C. [1 ]
Weintraub, W. [4 ]
Effron, M. [5 ]
Pocock, S. [6 ]
Keller, S. [5 ]
Kini, A. [1 ]
Strauss, C. [7 ]
Mehran, R. [1 ]
Kapadia, S. [8 ]
机构：
[1] Mt Sinai Med Ctr, New York, NY 10029 USA
[2] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[3] Duke Univ, Med Ctr, Chapel Hill, NC USA
[4] Christiana Hosp, Newark, DE USA
[5] Eli Lilly & Co, Indianapolis, IN 46285 USA
[6] London Sch Hyg & Trop Med, London, England
[7] Minneapolis Heart Inst Fdn, Minneapolis, MN USA
[8] Cleveland Clin, Cleveland, OH 44106 USA
来源：
EUROPEAN HEART JOURNAL | 2016年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5608
引用
收藏
页码：1164 / 1164
页数：1
相关论文
共 50 条
  • [31] Ticagrelor vs Clopidogrel for Patients With Acute Coronary Syndrome Undergoing Percutaneous Intervention
    Kim, Hyun Kuk
    Kubica, Jacek
    Jeong, Young-Hoon
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (09): : 890 - 890
  • [32] Use of prasugrel vs clopidogrel and outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention in contemporary clinical practice: Results from the PROMETHEUS study
    Haber, Usman
    Sartori, Samantha
    Aquino, Melissa
    Kini, Annapoorna
    Kapadia, Samir
    Weiss, Sandra
    Strauss, Craig
    Muhlestein, J. Brent
    Toma, Catalin
    Rao, Sunil V.
    DeFranco, Anthony
    Poddar, Kanhaiya L.
    Chandrasekhar, Jaya
    Weintraub, William
    Henry, Timothy D.
    Bansilal, Sameer
    Baker, Brian A.
    Marrett, Elizabeth
    Keller, Stuart
    Effron, Mark
    Pocock, Stuart
    Mehran, Roxana
    AMERICAN HEART JOURNAL, 2017, 188 : 73 - 81
  • [33] Effects of prasugrel versus clopidogrel on coronary microvascular function in patients undergoing elective percutaneous coronary intervention: a randomized double-blind study
    Mangiacapra, F.
    Pellicano, M.
    Di Serafino, L.
    Bressi, E.
    Peace, A.
    Di Gioia, G.
    Bartunek, J.
    Wijns, W.
    De Bruyne, B.
    Barbato, E.
    EUROPEAN HEART JOURNAL, 2015, 36 : 682 - 682
  • [34] Prasugrel versus ticagrelor for acute coronary syndrome patients undergoing percutaneous coronary intervention: A critical appraisal of randomized controlled trials
    Almas, Talal
    Ehtesham, Maryam
    Basit, Janita
    Khedro, Tarek
    Malik, Uzair
    Nagarajan, Vikneswaran Raj
    Hur, Jung
    Alshareef, Norah
    Fathima, Areen
    Virk, Hafeez Ul Hassan
    Hameed, Aamir
    Li, Jun
    ANNALS OF MEDICINE AND SURGERY, 2022, 74
  • [35] Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US
    Katherine A. Lyseng-Williamson
    American Journal of Cardiovascular Drugs, 2012, 12 : 207 - 216
  • [36] Prasugrel: A Guide to Its Use in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the US
    Lyseng-Williamson, Katherine A.
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2012, 12 (03) : 207 - 216
  • [37] Effects of prasugrel versus clopidogrel on coronary microvascular function in patients undergoing elective percutaneous coronary intervention: A randomized double-blind study
    Bressi, E.
    Mangiacapra, F.
    Pellicano, M.
    Di Serafino, L.
    Peace, A.
    Bartunek, J.
    Wijns, W.
    De Bruyne, Be
    Barbato, E.
    VASCULAR PHARMACOLOGY, 2015, 75 : 42 - 42
  • [38] Impact of Ticagrelor vs. Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Left Main Percutaneous Coronary Intervention
    Qiu, Miaohan
    Zhi, Xuehan
    Liu, Haiwei
    Liang, Zhenyang
    Wang, Bin
    Xu, Kai
    Guan, Shaoyi
    Wang, Geng
    Wang, Xiaozeng
    Ma, Yingyan
    Jing, Quanmin
    CARDIOLOGY DISCOVERY, 2025, 5 (01): : 39 - 46
  • [39] Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis
    Wongsalap, Yuttana
    Ungsriwong, Supakorn
    Kumtep, Wanalee
    Saokaew, Surasak
    Senthong, Vichai
    Kengkla, Kirati
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 991 - 1000
  • [40] Efficacy and Safety of Low-Dose Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis
    Yuttana Wongsalap
    Supakorn Ungsriwong
    Wanalee Kumtep
    Surasak Saokaew
    Vichai Senthong
    Kirati Kengkla
    Cardiovascular Drugs and Therapy, 2022, 36 : 991 - 1000
12345